Robert G. Kilbourn

NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide.

Robert G. Kilbourn, Steven S. Gross, Amal Jubran et al. · Proceedings of the National Academy of Sciences · 1990 · 654 citations · Full text

Excess L-arginine, Hypertension, Nitric Oxide +16

A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors.

C. Logothetis, F. H. Dexeus, Laura Finn et al. · Journal of Clinical Oncology · 1990 · 616 citations

Urological Research, Urology, Genitourinary Cancer +15

Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis

Robert G. Kilbourn, Amal Jubran, Steven S. Gross et al. · Biochemical and Biophysical Research Communications · 1990 · 557 citations

Biochemistry, Reactive Nitrogen Specie, Medicine +7

Endothelial Cell Production of Nitrogen Oxides in Response to Interferon   in Combination With Tumor Necrosis Factor, Interleukin-1, or Endotoxin

Robert G. Kilbourn, Paula Belloni · JNCI Journal of the National Cancer Institute · 1990 · 468 citations

Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages

Steven S. Gross, Eric Jaffe, Roberto Levi et al. · Biochemical and Biophysical Research Communications · 1991 · 390 citations

Inflammation, Cytokine, Lung Inflammation +11